| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2006-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b26558f7ca6d026cfc9e7073f3cb33c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1964337e240f7af1764cf309c82b34aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88bd91daa7285b2fb3cb0c2bc8cb4cbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7f3daebaefaa96511e245e67c0f1a74 |
| publicationDate |
2007-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PE-20070377-A1 |
| titleOfInvention |
LIQUID FORMULATIONS FOR THE CONTROLLED ADMINISTRATION OF BENZISOXAZOLE DERIVATIVES |
| abstract |
REFERRED TO A DOSAGE FORM THAT INCLUDES A CONTROLLED RELEASE DOSAGE STRUCTURE AND A LIQUID FORMULATION CONTAINED WITHIN THE CONTROLLED RELEASE DOSAGE STRUCTURE, WHERE THE LIQUID FORMULATION INCLUDES A LIQUID DERIVATIVE OF VEHICOSXOLO. THE BENCISOXAZOLE DERIVATIVE IS SELECTED FROM PALIPERIDONE OR RISPERIDONE AND IS FOUND IN A QUANTITY OF BETWEEN 0.1 MG TO 20 MG; THE LIQUID VEHICLE INCLUDES A LIPOPHILIC SOLVENT, A SURFACTANT OR A HYDROPHILIC SOLVENT. SUCH DOSAGE FORM PRESENTS IMPROVED BIOAVAILABILITY |
| priorityDate |
2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |